113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04624750 (ClinicalTrials.gov)	September 3, 2021	20/10/2020	Open Label Study in Adolescents and Children With Myotonic Disorders	An Open-label, Non-Comparative Study to Evaluate the Steady-State Pharmacokinetics, Safety, and Effi ...	Myotonic Dystrophy	Drug: Mexiletine	Lupin Ltd.	NULL	Recruiting	6 Years	18 Years	All	14	Phase 3	France
2	NCT04700046 (ClinicalTrials.gov)	July 6, 2021	5/1/2021	Study to Investigate the Efficacy and Safety of Mexiletinein Patients With Myotonic Dystrophy Type 1 ...	A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Investigate the Efficacy and S ...	Myotonic Dystrophy Type 1 and Type 2	Drug: Mexiletine 167 mg;Drug: Placebo	Lupin Ltd.	NULL	Not yet recruiting	18 Years	N/A	All	158	Phase 3	NULL
3	NCT04616807 (ClinicalTrials.gov)	December 17, 2020	23/10/2020	An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders	An Observational Study to Describe the Long-term Safety and Effectiveness of Namuscla in the Symptom ...	Myotonic Dystrophy	Drug: Mexiletine	Lupin Ltd.	NULL	Active, not recruiting	18 Years	N/A	All	53		France;Germany;United Kingdom
4	NCT01406873 (ClinicalTrials.gov)	June 2011	20/7/2011	Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1	A Randomized, Placebo Controlled, Clinical Efficacy Trial of Mexiletinefor Myotonic Dystrophy Type-1 ...	Myotonic Dystrophy	Drug: Mexiletine;Drug: Placebo	University of Rochester	NULL	Completed	18 Years	80 Years	All	42	Phase 2	United States

First Previous1Next Last